These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 26750397)

  • 21. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering.
    Saifaldeen M; Al-Ansari DE; Ramotar D; Aouida M
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
    Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
    Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biased and Unbiased Methods for the Detection of Off-Target Cleavage by CRISPR/Cas9: An Overview.
    Martin F; Sánchez-Hernández S; Gutiérrez-Guerrero A; Pinedo-Gomez J; Benabdellah K
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.
    Koo T; Lee J; Kim JS
    Mol Cells; 2015 Jun; 38(6):475-81. PubMed ID: 25985872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-target effects of engineered nucleases.
    Yee JK
    FEBS J; 2016 Sep; 283(17):3239-48. PubMed ID: 27208701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
    Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
    Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Editing on Center Stage.
    Bak RO; Gomez-Ospina N; Porteus MH
    Trends Genet; 2018 Aug; 34(8):600-611. PubMed ID: 29908711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
    He Z; Kee K
    Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive overview of computational resources to aid in precision genome editing with engineered nucleases.
    Periwal V
    Brief Bioinform; 2017 Jul; 18(4):698-711. PubMed ID: 27373734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.
    Shamshirgaran Y; Liu J; Sumer H; Verma PJ; Taheri-Ghahfarokhi A
    Methods Mol Biol; 2022; 2495():29-46. PubMed ID: 35696026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OffScan: a universal and fast CRISPR off-target sites detection tool.
    Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
    BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating Cas9 activity for precision gene editing.
    Uslu M; Siyah P; Harvey AJ; Kocabaş F
    Prog Mol Biol Transl Sci; 2021; 181():89-127. PubMed ID: 34127203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Points of View on the Tools for Genome/Gene Editing.
    Chuang CK; Lin WM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool.
    Stemmer M; Thumberger T; Del Sol Keyer M; Wittbrodt J; Mateo JL
    PLoS One; 2015; 10(4):e0124633. PubMed ID: 25909470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases.
    Zischewski J; Fischer R; Bortesi L
    Biotechnol Adv; 2017; 35(1):95-104. PubMed ID: 28011075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.